CALL FOR PAPERS: VOLUME 1; NO. 1

2018-11-21

HH Publisher and Editor-in-Chief, Dr. Goh Bey Hing, invites all authors, researchers and academicians to submit manuscripts to our recently launched premium journal, Progress in Drug Discovery and Biomedical Science (PDDBS).

Progress in Drug Discovery and Biomedical Science is an open access journal dedicated to the exchange of information and understandings about the research in areas of drug discovery and biomedical science based on the principles established through international conventions.

PDDBS is an open access journal that allows immediate visibility and access for research outputs as well as free usage of researchers’ results.

The journal rendering support to authors by:

  • Authors may retain their copyright.
  • The articles can be shared, re-used and archived without any cost.
  • Immediate response, minimal time for processing and publication.
  • Authors may self-archive once published to increase visibility.

 

All manuscripts will screen through a high standard protocol of double blind peer review. Each manuscript will be reviewed by at least 2 qualified reviewers from either Editorial Board or external penal expert based on the manuscript title. However, the final decision will be under Editor-in-Chief.

 

The manuscript management adhere to “Code of Conduct for Journal Editors and Code of Conduct for Publishers” and Best Practise as stipulated by Committee on Publication Ethics (COPE) to prevent misconduct of research papers.

 

Submission can be made under “Online Submission” icon on the journal home page. You may also click HERE to submit the articles.

 

Please be informed that you are required to register yourself in order to submit the article under your author profile.